CoChat

An Appraisal on the Value of Using Nutraceutical Based Senolytics and Senostatics in Aging

Open access
Kaur, Amanpreet, Macip, Salvador, Stover, Cordula M. · 2020 · Frontiers in Cell and Developmental Biology
Cited by 26

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

The average human life expectancy has increased globally, and continues to rise, owing to the substantive progress made in healthcare, medicine, sanitation, housing and education. This ultimately enriches society with a greater proportion of elderly people. Sustaining a healthy aged population is key to diminish the societal and economic impact of age-related infirmities. This is especially challenging because tissue function, and thus wellbeing, naturally progressively decline as humans age. With age increasing the risk of developing diseases, one of the therapeutic options is to interfere with the molecular and cellular pathways involved in age-related tissue dysfunction, which is in part caused by the accumulation of senescent cells. One strategy to prevent this could be using drugs that selectively kill these cells (senolytics). In parallel, some compounds have been identified that prevent or slow down the progression of senescence or some of its features (senostatics). Senolytic and senostatic therapies have been shown to be efficient in vivo, but they also have unwanted dose-dependent side effects, including toxicity. Important advances might be made using bioactive compounds from plants and foods (nutraceuticals) if, as is proposed, they offer similar effectiveness with fewer side effects. The focus of this review is on the use of nutraceuticals in interfering with cellular senescence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fcell.2020.00218

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Aird, 2012, Detection of senescence-associated heterochromatin foci (SAHF)., Methods Mol. Biol., 965, 185, 10.1007/978-1-62703-239-1_12 · DOI · Paper page
  2. Althubiti, 2016, BTK modulates p53 activity to enhance apoptotic and senescent responses., Cancer Res., 76, 5405, 10.1158/0008-5472.CAN-16-0690 · DOI
  3. Bailey, 2017, Metformin: historical overview., Diabetologia, 60, 1566, 10.1007/s00125-017-4318-z · DOI · Paper page
  4. Bernadotte, 2016, Markers of cellular senescence. Telomere shortening as a marker of cellular senescence., Aging, 8, 3, 10.18632/aging.100871 · DOI · Paper page
  5. Boothman, 2008, Stress-induced premature senescence (SIPS) – influence of SIPS on radiotherapy., J. Radiat. Res., 49, 105, 10.1269/jrr.07081 · DOI
  6. Calado, 2013, Telomere dynamics in mice and humans., Semin. Hematol., 50, 165, 10.1053/j.seminhematol.2013.03.030 · DOI · Paper page
  7. Ciccarone, 2018, DNA methylation dynamics in aging: how far are we from understanding the mechanisms?, Mech. Age. Dev., 174, 3, 10.1016/j.mad.2017.12.002 · DOI · Paper page
  8. Demidenko, 2009, At concentrations that inhibit mTOR, resveratrol suresses cellular senescence., Cell Cycle, 8, 1901, 10.4161/cc.8.12.8810 · DOI
  9. Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo., Cell Biol., 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
  10. Dimri, 2005, What has senescence got to do with cancer?, Cancer Cell, 7, 505, 10.1016/j.ccr.2005.05.025 · DOI · Paper page
  11. Freund, 2012, Lamin B1 loss is a senescence-associated biomarker., Mol. Biol. Cell, 23, 2066, 10.1091/mbc.E11-10-0884 · DOI · Paper page
  12. Fu, 2016, Effects of senescent lens epithelial cells on the severity of age-related cortical cataract in humans., Medicine, 95, 10.1097/MD.0000000000003869 · DOI
  13. Garbers, 2013, Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR)., Cell Cycle, 12, 3421, 10.4161/cc.26431 · DOI · Paper page
  14. Giaimo, 2012, Is cellular senescence an example of antagonistic pleiotropy?, Aging Cell, 11, 378, 10.1111/j.1474-9726.2012.00807.x · DOI
  15. Gilbert, 2000, Developmental biology, Aging: The Biology of Senescence
  16. Giovannelli, 2012, Beneficial effects of olive oil phenols on the aging process: experimental evidence and possible mechanisms of action., Nutr. Aging, 1, 207, 10.3233/nua-130016 · DOI
  17. González-Hunt, 2018, DNA damage by oxidative stress: measurement strategies for two genomes., Curr. Opin. Toxicol., 7, 87, 10.1016/j.cotox.2017.11.001 · DOI
  18. Han, 2012, Preventative effects of Epigallocatechin-3-O-Gallate against replicative senescence associated with p53 acetylation in human dermal fibroblasts., Oxid. Med. Cell. Longev., 2012, 10.1155/2012/850684 · DOI
  19. Hayflick, 1961, The serial cultivation of human diploid cell strains., Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
  20. Hernández-Segura, 2018, Hallmarks of cellular senescence., Trends Cell Biol., 28, 436, 10.1016/j.tcb.2018.02.001 · DOI · Paper page
  21. Huang, 2014, Senescence-associated β-galactosidase activity marks the visceral endoderm of mouse embryos but is not indicative of senescence., Genesis, 52, 300, 10.1002/dvg.22761 · DOI
  22. Jackson, 2009, The DNA-damage response in human biology and disease., Nature, 461, 1071, 10.1038/nature08467 · DOI · Paper page
  23. Jeon, 2018, Senescent cells and osteoarthritis: a painful connection., J. Clin. Investig., 128, 1229, 10.1172/JCI95147 · DOI · Paper page
  24. Jeon, 2018, Anti-inflammatory and anti-aging effects of hydroxytyrosol on human dermal fibroblasts (HDFs)., Biomed. Dermatol., 2, 10.1186/s41702-018-0031-x · DOI
  25. Jingwen, 2017, Cell cycle regulation and anticancer drug discovery., Cancer Biol. Med., 14, 348, 10.20892/j.issn.2095-3941.2017.0033 · DOI · Paper page
  26. Katsiki, 2007, The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts., Rejuvenat. Res., 10, 157, 10.1089/rej.2006.0513 · DOI · Paper page
  27. Khan, 2016, Generating primary fibroblast cultures from mouse ear and tail tissues., J. Vis. Exp., 107, 10.3791/53565 · DOI
  28. Khan, 2013, Fisetin: a dietary antioxidant for health promotion., Antioxid. Redox Signal., 19, 151, 10.1089/ars.2012.4901 · DOI · Paper page
  29. Kim, 2018, Skin protective effect of epigallocatechin gallate., Int. J. Mol. Sci., 19, 10.3390/ijms19010173 · DOI · Paper page
  30. Ko, 2018, Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF., Cell Death Diff., 25, 1050, 10.1038/s41418-018-0072-0 · DOI
  31. Kumar, 2018, Epigallocatechin gallate suresses premature senescence of preadipocytes by inhibition of PI3K/Akt/mTOR pathway and induces senescent cell death by regulation of Bax/Bcl-2 pathway., Biogerontology, 20, 171, 10.1007/s10522-018-9785-1 · DOI
  32. Malavolta, 2018, Inducers of senescence, toxic compounds, and senolytics: the multiple faces of Nrf2-activating phytochemicals in cancer adjuvant therapy., Mediators Inflamm., 2018, 1, 10.1155/2018/4159013 · DOI
  33. Marković, 2019, Hydroxytyrosol, tyrosol and derivatives and their potential effects on human health., Molecules, 24, 10.3390/molecules24102001 · DOI · Paper page
  34. Menicacci, 2017, Modulation of the senescence-associated inflammatory phenotype in human fibroblasts by olive phenols., Int. J. Mol. Sci., 18, 10.3390/ijms18112275 · DOI · Paper page
  35. Miller, 2010, Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice., J. Gerontol. Ser. A, 191, 10.1093/gerona/glq178 · DOI · Paper page
  36. PubChem Database(-)-Epigallocatechin gallate, CID=65064.
  37. PubChem Database Fisetin, CID=5281614.
  38. PubChem Database Hydroxytyrosol, CID=82755.
  39. PubChem Database Oleuropein aglycone, CID=56842347.
  40. PubChem Database Resveratrol, CID=445154.
  41. Niu, 2013, The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats., Aging Cell, 12, 1041, 10.1111/acel.12133 · DOI · Paper page
  42. Paez-Ribes, 2019, Targeting senescent cells in translational medicine., EMBO Mol. Med., 11, 10.15252/emmm.201810234 · DOI · Paper page
  43. Qian, 2012, Senescence regulation by the p53 protein family., Methods Mol. Biol., 965, 37, 10.1007/978-1-62703-239-1_3 · DOI · Paper page
  44. Rafieian-Kopaei, 2014, New concepts in nutraceuticals as an alternative for pharmaceuticals., Int. J. Prevent. Med., 5, 1487
  45. Risuleo, 2016, Resveratrol., Nutraceuticals, 5, 453, 10.1016/B978-0-12-802147-7.00033-4 · DOI
  46. Sáez, 2014, The mechanistic links between proteasome activity, aging and age-related diseases., Curr. Genomics, 15, 38, 10.2174/138920291501140306113344 · DOI · Paper page
  47. Salehi, 2018, Resveratrol: a double-edged sword in health benefits., Biomedicines, 6, 10.3390/biomedicines6030091 · DOI · Paper page
  48. Serrano, 2014, Cellular senescence: from physiology to pathology., Nat. Rev. Mol. Cell Biol., 15, 482, 10.1038/nrm3823 · DOI · Paper page
  49. Shammas, 2011, Telomeres, lifestyle, cancer, and aging., Curr. Opin. Clin. Nutr. Metab. Care, 14, 28, 10.1097/mco.0b013e32834121b1 · DOI · Paper page
  50. Short, 2019, Senolytics and senostatics as adjuvant tumour therapy., EBioMedicine, 41, 683, 10.1016/j.ebiom.2019.01.056 · DOI · Paper page
  51. Strong, 2012, Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice., J. Gerontol. Ser. A Biol. Sci. Med. Sci., 68, 6, 10.1093/gerona/gls070 · DOI · Paper page
  52. Sun, 2017, Oleuropein, unexpected benefits!, Oncotarget, 8
  53. Tabasso, 2019, Radiotherapy-induced senescence and its effects on responses to treatment., Clin. Oncol., 31, 283, 10.1016/j.clon.2019.02.003 · DOI
  54. Tsoukalas, 2019, Discovery of potent telomerase activators: unfolding new therapeutic, and anti-aging perspectives., Mol. Med. Rep., 20, 3701, 10.3892/mmr.2019.10614 · DOI
  55. Tuck, 2002, Major phenolic compounds in olive oil: metabolism and health effects., J. Nutr. Biochem., 13, 636, 10.1016/s0955-2863(02)00229-2 · DOI · Paper page
  56. Unno, 2016, Prevention of brain aging by green tea components: role of catechins and theanine., J. Phys. Fitness Sports Med., 5, 117, 10.7600/jpfsm.5.117 · DOI
  57. Unno, 2006, Daily consumption of green tea catechin delays memory regression in aged mice., Biogerontology, 8, 89, 10.1007/s10522-006-9036-8 · DOI
  58. van Deursen, 2014, The role of senescent cells in ageing., Nature, 509, 439, 10.1038/nature13193 · DOI · Paper page
  59. Wang, 2017, Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism., Aging Cell, 16, 564, 10.1111/acel.12587 · DOI · Paper page
  60. Xia, 2009, Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms., Br. J. Pharmacol., 155, 387, 10.1038/bjp.2008.272 · DOI
  61. Yao, 2014, Modelling mammalian cellular quiescence., Interface Focus, 4, 10.1098/rsfs.2013.0074 · DOI · Paper page
  62. Yousefzadeh, Mouse models of accelerated cellular senescence., Methods Mol. Biol., 1896, 203, 10.1007/978-1-4939-8931-7_17 · DOI
  63. Zhang, 2016, Human specific regulation of the telomerase reverse transcriptase gene., Genes, 7, 10.3390/genes7070030 · DOI

Cited by

See all 26

Metadata

Authors
Kaur, A., Macip, S., & Stover, C. M.
Venue
Frontiers in Cell and Developmental Biology
Published
2020-04-03
Volume
8
Pages
218-218
ISSN
2296-634X (ISSN-L)
OpenAlex
W3014546834
Cited by
26
References
32
FWCI
2.39
Type
journal article
Language
en
Open access
gold
Funders
Biotechnology and Biological Sciences Research Council

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.